|-- Q2 2012 Press Release:||August 2, 2012 at 7:00 a.m. ET|
|-- Q2 2012 Conference Call:||August 2, 2012 at 8:30 a.m. ET|
|-- Domestic Dial In Number:||877-407-8037|
|-- International Dial In Number:||201-689-8037|
|-- Conference ID #||397266|
For as much as we love and respect you, Gilead, the current situation is unacceptable. The once great and mighty biotech Gilead cannot trade at a 6x forward earnings multiple!
Investors have convinced themselves that President Donald Trump is going to make drug stocks great again. Will it last?